ArticlePediatric cardiology2026
Percutaneous Closure of Coronary Sinus Atrial Septal Defect across Two Spectrums: A Case Series.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary Sinus ASD or Unroofed Coronary Sinus defect is the rarest form of atrial septal defect and is seldom reported due to its non specific manifestations and difficult diagnosis on transthoracic echocardiography. Multimodality imaging is required for accurate diagnosis of this defect. The standard treatment is surgical and it has been incidentally diagnosed during other cardiac surgeries. Here we present two such patients who presented to us with non-specific complaints and were incidentally detected to have RA, RV dilatation. On detailed transthoracic and transoesophageal echocardiography, they were found to have a coronary sinus ASD; one with a persistent left vena cava (PLSVC) and another without a PLSVC. They were both closed using atrial septal occluder defect percutaneously. Transcutaneous closure of this defect is possible after meticulous planning and proper understanding of the anatomy. It is safe and can be performed if this defect is diagnosed correctly.
Indexed as
Identifiers
42489900What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.